Article Text

Download PDFPDF
Visual compatibility and particle counter evaluations of syringes of intramuscular psychotropic coadministered solutions
  1. Lydia Djerroud1,2,
  2. Gregoire Leclair1,3,
  3. Thomas Sullivan2,
  4. Vincent Dagenais-Beaulé1,2,4
  1. 1Faculté de Pharmacie, Université de Montréal, Montreal, Québec, Canada
  2. 2Pharmacy, Jewish General Hospital, Montreal, Québec, Canada
  3. 3Groupe de Recherche Universitaire sur le Médicament, Université de Montréal, Montreal, Québec, Canada
  4. 4Lady Davis Institute, Jewish General Hospital, Montreal, Quebec, Canada
  1. Correspondence to Dr Vincent Dagenais-Beaulé, Pharmacy, Jewish General Hospital, Montreal, QC H3T 1E2, Canada; vdagenaisbeaule{at}jgh.mcgill.ca

Abstract

Background Patients in the acute phase of agitation can require the administration of multiple drugs by intramuscular injection in order to temporarily stabilise their condition. Administration of multiple psychotropic medications in a single syringe can be beneficial to both the patient and healthcare professionals. However, there are very little data in the literature regarding psychotropic drug compatibility in syringes for acute agitation.

Objective The aim of this study was to assess the visual compatibility of various combinations of 12 intramuscular psychotropic medications in syringes, and to validate compatibility with the use of a particle counter. The medications evaluated were benztropine mesylate, diazepam, dimenhydrinate, diphenhydramine hydrochloride, haloperidol lactate, hydroxyzine, lorazepam, loxapine, methotrimeprazine, midazolam, olanzapine and zuclopenthixol acetate.

Methods Compounded solutions of medication combinations underwent visual inspection initially and after 0.25, 0.5, 1, 2 and 4 hours using a white background and a black background. In order to validate the compatibility results, the presence of particulate matter was determined by light obscuration.

Results This study identified 35 combinations that were visually compatible and 35 that were visually incompatible. We chose eight highly clinically relevant combinations to test using the requirements of the United States Pharmacopoeia (USP) chapter <788> (Particulate Matter in Injections). Of those eight, six were physically compatible, including the triple combinations of lorazepam and haloperidol with either benztropine or diphenhydramine.

Conclusion These physical compatibility results will give healthcare professionals an idea of the possible compatible combinations of psychotropic drugs in syringes, and thus complete some of the missing data in the literature.

  • drug incompatibility
  • analytic sample preparation methods
  • chemistry, clinical
  • pharmaceutical preparations
  • safety
  • mental health
  • psychiatry

Data availability statement

All data relevant to the study are included in the article or uploaded as supplementary information.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Data availability statement

All data relevant to the study are included in the article or uploaded as supplementary information.

View Full Text